Fortis Healthcare reported strong Q2 FY26 results, with consolidated revenue reaching INR 2,331 crores, a 17.3% increase year-over-year. The hospital business saw a 19.3% revenue increase, and diagnostics grew by 7.1%. Operating EBITDA rose by 28% to INR 556 crores. The company is expanding, adding 550 operational beds in H1 FY26. Oncology and medical travel segments demonstrated impressive growth. The company expects continued revenue and margin improvements, including from recent acquisitions and expansions.
Financial Performance
Fortis Healthcare announced its Q2 FY26 earnings, showcasing significant growth across its key business segments. Highlights include:
- Consolidated revenue of INR 2,331 crores, up 17.3% from the previous year.
- Hospital business revenue increased by 19.3% to INR 1,974 crores.
- Diagnostic business net revenue grew by 7.1% to INR 357 crores.
- Operating EBITDA increased by 28% to INR 556 crores, with a margin of 23.9%.
- Profit after tax before exceptional items increased by 20.7% to INR 305 crores.
For the first half of the fiscal year, consolidated revenues reached INR 4,498 crores, a 16.9% increase, and operating EBITDA rose to INR 1,047 crores, reflecting a robust 310-point improvement to 23.3%.
Hospital Business
The hospital business continues to be a key driver of growth for Fortis Healthcare. Key metrics include:
- 19% increase in revenue for H1 FY26, reaching INR 3,812 crores.
- Operating margin improved by 250 basis points to 22.5%.
- Occupancy improved to 71%.
- ARPOB (Average Revenue Per Occupied Bed) increased by 5.8% to INR 2.51 crores per annum, driven by a stronger specialty mix, especially in oncology.
- Oncology segment grew 29% year-on-year, contributing 16.2% to revenue.
- Medical travel revenue grew 26% to INR 169 crores.
Agilus Diagnostics
Agilus Diagnostics also reported positive results:
- Revenue of INR 399.6 crores in Q2 FY26, a growth of 7.3%.
- Operating EBITDA stood at INR 104 crores, with margins improving to 26.1%.
- For H1 FY26, revenue reached INR 768 crores, with an EBITDA of INR 189 crores, a margin of 24.6%.
Expansion and Strategy
Fortis Healthcare is actively expanding its capacity and network. Highlights include:
- Added 550 operational beds in H1 FY26, including acquisitions and new arrangements.
- Entered a 15-year lease agreement for a 200-bed multi-specialty hospital in Greater Noida.
- Signed an O&M agreement for a 550-bed greenfield super specialty hospital in Lucknow.
- Acquired Shrimann Super speciality Hospital in Jalandhar.
The company expects to sustain its growth trajectory and will continue to explore growth opportunities within its focused geographies.
Source: BSE